Your browser doesn't support javascript.
Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure.
Ghale, Rajani; Spottiswoode, Natasha; Anderson, Mark S; Mitchell, Anthea; Wang, Grace; Calfee, Carolyn S; DeRisi, Joseph L; Langelier, Charles R.
  • Ghale R; Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco, CA, USA.
  • Spottiswoode N; Division of Infectious Diseases, University of California, San Francisco, CA, USA.
  • Anderson MS; Department of Medicine, University of California, San Francisco, CA, USA.
  • Mitchell A; Division of Infectious Diseases, University of California, San Francisco, CA, USA.
  • Wang G; Department of Medicine, University of California, San Francisco, CA, USA.
  • Calfee CS; Department of Medicine, University of California, San Francisco, CA, USA.
  • DeRisi JL; Diabetes Center, University of California, San Francisco, CA, USA.
  • Langelier CR; Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA.
Respir Res ; 23(1): 354, 2022 Dec 16.
Artículo en Inglés | MEDLINE | ID: covidwho-2196285
ABSTRACT
Auto-antibodies (Abs) to type I interferons (IFNs) are found in up to 25% of patients with severe COVID-19, and are implicated in disease pathogenesis. It has remained unknown, however, whether type I IFN auto-Abs are unique to COVID-19, or are also found in other types of severe respiratory illnesses. To address this, we studied a prospective cohort of 284 adults with acute respiratory failure due to causes other than COVID-19. We measured type I IFN auto-Abs by radio ligand binding assay and screened for respiratory viruses using clinical PCR and metagenomic sequencing. Three patients (1.1%) tested positive for type I IFN auto-Abs, and each had a different underlying clinical presentation. Of the 35 patients found to have viral infections, only one patient tested positive for type I IFN auto-Abs. Together, our data suggest that type I IFN auto-Abs are uncommon in critically ill patients with acute respiratory failure due to causes other than COVID-19.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Insuficiencia Respiratoria / Interferón Tipo I / COVID-19 Tipo de estudio: Estudio de cohorte / Estudios diagnósticos / Estudio observacional / Estudio pronóstico Límite: Adulto / Humanos Idioma: Inglés Revista: Respir Res Año: 2022 Tipo del documento: Artículo País de afiliación: S12931-022-02283-4

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / Insuficiencia Respiratoria / Interferón Tipo I / COVID-19 Tipo de estudio: Estudio de cohorte / Estudios diagnósticos / Estudio observacional / Estudio pronóstico Límite: Adulto / Humanos Idioma: Inglés Revista: Respir Res Año: 2022 Tipo del documento: Artículo País de afiliación: S12931-022-02283-4